Chinook: Chinook Therapeutics files patent for a method of treating diabetic kidney disease
Discover a groundbreaking method for treating diabetic kidney disease and chronic kidney disease associated with diabetes. This patent-approved treatment combines atrasentan and a SGLT-2 inhibitor to improve kidney function, reduce kidney damage, and enhance heart health. Find out more!
Read full article »
Chinook is a Washington-based clinical-stage biopharmaceutical company that researches and develops precision drugs for the treatment of chronic kidney disease.
Read more